Skip to main content
Premium Trial:

Request an Annual Quote

IROA, Cambridge Isotope Labs Ink Commercialization Deal

NEW YORK (GenomeWeb) – Cambridge Isotope Laboratories has announced a deal with IROA Technologies to develop and distribute metabolite quantitation kits for mass spectrometry-based profiling.

Under the terms of the agreement, the partners will work on IROA's Biochemical Quantitation Kits, which chemically label metabolites for isotopic ratio outlier analysis.  In a statement, the firms said the kits can help researchers eliminate technical and analytical variance, thus increasing reliability.

Financial and other terms of the agreement were not disclosed.

A year ago, Ann Arbor, Michigan-based IROA signed an exclusive distribution deal for the Mass Spectrometry Metabolite Library of Standards with Sigma-Aldrich, now known in the US as MilliporeSigma following its acquisition by Merck KGaA.

Tewksbury, Massachusetts-based Cambridge Isotope Labs has commercialization deals with several proteomic- and metabolomic-focused companies, including Nexomics and MRM Proteomics.